This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Turaga, K. K. Articles by Forse, R. A. Search for Related Content PubMed PubMed Citation Articles by Turaga, K. K. Articles by Forse, R. A. Social Bookmarking                         What's this?

A Meta-analysis of Randomized Controlled Trials in Critically Ill Patients to Evaluate the Dose-Response Effect of Erythropoietin

Department of Surgery, Creighton University Medical Center, Omaha, NE

Jeffrey T. Sugimoto, MD

Department of Surgery, Creighton University Medical Center, Omaha, NE

R. Armour Forse, MD, PhD

Department of Surgery, Creighton University Medical Center, Omaha, NE, aforse{at}creighton.edu

The use of erythropoietin in critically ill patients has been investigated in multiple randomized clinical trials and its role in decreasing the number of units of blood transfused has been demonstrated in some trials. A meta-analysis was conducted to determine the pooled estimate of the decrease in number of units of blood transfused with the use of erythropoietin and investigated its dose-response effect. A systematic search was performed of the MEDLINE, EMBASE, and the Current Controlled Trials Register to identify randomized clinical trials investigating the role of erythropoietin in critically ill patients. Of 664 studies identified in the search, 5 randomized clinical trials met the inclusion criteria. The pooled estimate of the decrease of number of units of blood transfused was —1.64 (95% CI —2.6 to —0.67). Sensitivity analysis to establish the influence of temporal bias, quality of the study and comorbidities such as age and Acute Physiology and Chronic Health Evaluation (APACHE) II score were undertaken and did not reveal a significant difference. The inclusion of studies with higher doses of erythropoietin revealed a greater decrease in the number of units of blood transfused (—2.15; 95% CI —3.06 to —1.24). Despite the limitations of a meta-analysis we believe that the use of erythropoietin significantly decreases the number of units of blood transfused per patient. Our study also reveals the possibility of a dose-response effect of erythropoietin in decreasing the number of units of blood transfused.

Key Words: erythropoietin • critical care • ICU • blood transfusion • dose-response effect

Journal of Intensive Care Medicine, Vol. 22, No. 5, 270-282 (2007)
DOI: 10.1177/0885066607304437


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?